{"title":"Photodynamic therapy for head and neck tumors","authors":"P. Lou","doi":"10.1109/APBP.2004.1412281","DOIUrl":null,"url":null,"abstract":"Studies in the past have confirmed the safety and efficacy of photodynamic therapy (PDT) in the treatment of various human cancers. Because of the concern for cosmetic and functional preservation, PDT seems to be particularly suited for head and neck tumor treatment. Results from previous studies are promising. Good cosmetic and functional outcomes can be achieved without compromising the patients' survival. PDT is a therapeutic option that may prove a useful addition to the armamentarium of the integrated head and neck oncology team.","PeriodicalId":346624,"journal":{"name":"The Second Asian and Pacific Rim Symposium on Biophotonics, 2004. APBP 2004.","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2004-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Second Asian and Pacific Rim Symposium on Biophotonics, 2004. APBP 2004.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/APBP.2004.1412281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Studies in the past have confirmed the safety and efficacy of photodynamic therapy (PDT) in the treatment of various human cancers. Because of the concern for cosmetic and functional preservation, PDT seems to be particularly suited for head and neck tumor treatment. Results from previous studies are promising. Good cosmetic and functional outcomes can be achieved without compromising the patients' survival. PDT is a therapeutic option that may prove a useful addition to the armamentarium of the integrated head and neck oncology team.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
